SFA Therapeutics Extends Patent Protection for Drug Platform
JENKINTOWN, PA — SFA Therapeutics has secured a new U.S. patent covering a class of modified short-chain fatty acid compounds, strengthening intellectual property protection around its drug development platform and …
SFA Therapeutics Extends Patent Protection for Drug Platform Read More